Monopar Therapeutics Inc.
USD60.56
-0.70 (-1.14%)
CEO
Chandler D. Robinson
IPO Date
2019-12-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$59.44
Prev. Close
$61.26
Day Low
$57.87
Day High
$61.12
52W Low
$29.18
52W High
$105.00
Market Cap
$0.41B
Volume
0.07M
| 1,972 |
| $54.79 |
| 2 Apr 2026 | Robinson Chandler | director, officer: Chief Executive Officer | M-Exempt | Disposed | 6,732 | $0.00 |
| 2 Apr 2026 | Cittadine Andrew | Chief Operating Officer | M-Exempt | Acquired | 3,514 | $0.00 |
| 2 Apr 2026 | Cittadine Andrew | Chief Operating Officer | F-InKind | Disposed | 1,571 | $54.79 |
| 2 Apr 2026 | Cittadine Andrew | Chief Operating Officer | M-Exempt | Disposed | 3,514 | $0.00 |
| 4 Mar 2026 | Rodriguez Susan | CCSO | A-Award | Acquired | 48,728 | $53.47 |
| 4 Mar 2026 | Rodriguez Susan | officer | Disposed | 0 | $0.00 |
| 30 Jan 2026 | Robinson Chandler | director, officer: Chief Executive Officer | J-Other | Acquired | 62,815 | $0.00 |
| 5 Jan 2026 | Robinson Chandler | director, officer: Chief Executive Officer | M-Exempt | Acquired | 8,724 | $0.00 |